GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Zim Laboratories Ltd

Zim Laboratories Board to Consider Q2 FY27 Unaudited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 28 Oct 2026, 04:12 PM IST  ·  BSE ID: 01a3aab8-6a17-4018-ba6a-4f84848213b9
View Original BSE Filing (PDF)
💡
In Simple Terms
Zim Laboratories' board will meet on November 4, 2026, to approve financial results for the September 2026 quarter.
🤖 AI Summary
  • Zim Laboratories Board meeting scheduled for Wednesday, November 04, 2026.
  • The Board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
  • Trading window for company securities is closed from October 01, 2026, to November 06, 2026.
  • The closure applies to both days inclusive, as per SEBI Insider Trading Regulations, 2015.
👥 What This Means For Shareholders
✅
Action Required
No direct action is required from shareholders based on this intimation.
👤
Who Is Affected
Shareholders will be indirectly affected by the upcoming financial results, which will provide an update on the company's performance. Insiders are restricted from trading company securities during the stated window.
🔍
Management Signal
The scheduling of the Board meeting indicates adherence to regulatory requirements for timely disclosure of financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome on November 04, 2026.
Unaudited Financial Results for Q2 FY27.
Any management commentary post results announcement.
LOW RISK The filing is a routine announcement of a board meeting for results approval.
💡 Investor Takeaway
Zim Laboratories Ltd has announced a Board meeting on November 04, 2026, to approve unaudited standalone and consolidated financial results for the quarter ended September 30, 2026. The trading window is closed from October 01, 2026, to November 06, 2026.
📅 Company Track Record
Zim Laboratories reported a consolidated net loss of Rs. (401.70) lakhs for the quarter ended June 30, 2026. The company also scheduled a Q4 and FY26 earnings call on May 20, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Zim Laboratories Ltd's Board meeting scheduled?
Zim Laboratories Ltd's Board of Directors meeting is scheduled for Wednesday, November 04, 2026.
What will be considered at the Zim Laboratories Ltd Board meeting on November 04, 2026?
The Board will consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended September 30, 2026.
What are the dates for the trading window closure for Zim Laboratories Ltd?
The trading window for dealing with securities of Zim Laboratories Ltd is closed from Thursday, October 01, 2026, to Friday, November 06, 2026, both days inclusive.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.